Maryland man blames Ozempic for blindness

A Maryland man has filed a lawsuit against Novo Nordisk, claiming that using the diabetes and weight-loss drug Ozempic led to sudden and permanent vision loss. Todd Engel experienced nonarteritic anterior ischemic optic neuropathy (NAION) in both eyes after several months of taking the medication, which he believes caused his blindness. Despite ongoing litigation and concerns from patients, the manufacturer denies a causal link between semaglutide and NAION, stating that available evidence does not confirm such a relationship. Engel now uses a cane and relies on family for daily activities, and he has spoken out to warn others about potential risks.

articleDetails.fontSize.sizeحجم النص

تنويه: هذا ملخص تم إنشاؤه بواسطة الذكاء الاصطناعي

عرض المقال بالكامل